BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2143957)

  • 1. Cardiovascular effects of central injection of acetylcholine in anaesthetized dogs: a role for vasopressin release.
    Rascol O; Montastruc JL; Gauquelin G; Tran MA; Geelen G; Gharib C; Montastruc P
    Br J Pharmacol; 1990 Jul; 100(3):471-6. PubMed ID: 2143957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cardiovascular effects of acetylcholine in the conscious dog.
    Brefel C; Lazartigues E; Tran MA; Gauquelin G; Geelen G; Gharib C; Montastruc JL; Montastruc P; Rascol O
    Br J Pharmacol; 1995 Oct; 116(4):2175-82. PubMed ID: 8564246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of vasopressin in the cardiovascular effects of quinpirole.
    Damase-Michel C; Montastruc JL; Tran MA; Gharib C; Geelen G; Montastruc P
    Eur J Pharmacol; 1990 Aug; 184(1):179-83. PubMed ID: 1976526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adrenal medulla and neurohypophysis in the central and peripheral cardiovascular effects of neurohypophysial peptides.
    Montastruc JL; Dang Tran L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):299-308. PubMed ID: 6486975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vasopressin in cardiovascular and neurohormonal responses to intracerebroventricular hypertonic NaCl.
    Kawano Y; Ferrario CM
    Jpn Heart J; 1990 Mar; 31(2):237-44. PubMed ID: 1972413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing.
    Travill CM; Williams TD; Pate P; Song G; Chalmers J; Lightman SL; Sutton R; Noble MI
    Cardiovasc Res; 1992 Aug; 26(8):783-90. PubMed ID: 1451153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohypophysial peptides and central cardiovascular control.
    Montastruc JL; Dang Tran L; Montastruc P
    Eur Heart J; 1983 Nov; 4 Suppl G():47-50. PubMed ID: 6662121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus.
    Errington ML; Rocha e Silva M
    J Physiol; 1972 Dec; 227(2):395-418. PubMed ID: 4647250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular interactions between vasopressin, angiotensin and noradrenaline in the Brattleboro rat.
    Laycock JF; Lightman SL
    Br J Pharmacol; 1989 Feb; 96(2):347-55. PubMed ID: 2493961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic factor is biologically active also in the absence of vasopressin: studies on Brattleboro-strain diabetes insipidus rats.
    Obana K; Naruse M; Inagami T; Naruse K; Higashida T; Demura H; Shizume K
    Endocrinol Jpn; 1987 Jun; 34(3):335-8. PubMed ID: 2958271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release.
    Allal C; Lazartigues E; Tran MA; Brefel-Courbon C; Gharib C; Montastruc JL; Rascol O
    Eur J Pharmacol; 1998 May; 348(2-3):191-8. PubMed ID: 9652334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lysine-vasopressin and oxytocin on central cardiovascular control.
    Tran LD; Montastruc JL; Montastruc P
    Br J Pharmacol; 1982 Sep; 77(1):69-73. PubMed ID: 7126997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central indomethacin enhances volume-dependent vasopressin release.
    Brooks DP; Share L; Crofton JT; Nasjletti A
    Am J Physiol; 1984 Dec; 247(6 Pt 2):R1017-21. PubMed ID: 6391207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vasopressin in blood pressure regulation in conscious water-deprived dogs.
    Schwartz J; Reid IA
    Am J Physiol; 1983 Jan; 244(1):R74-7. PubMed ID: 6336915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANF.
    Ertl G; Bauer B
    Eur Heart J; 1990 Apr; 11 Suppl B():53-7. PubMed ID: 2142082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and hormonal changes following haemorrhage in the anaesthetized Brattleboro rat with an extracorporeal circulation.
    Hreash F; Laycock JF
    Pflugers Arch; 1990 Sep; 417(1):106-10. PubMed ID: 2293200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of injections of vasopressin into the nucleus tractus solitarius in conscious rats.
    King KA; Pang CC
    Br J Pharmacol; 1987 Mar; 90(3):531-6. PubMed ID: 3567458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological control of vasopressin release.
    Sladek JR; Sladek CD
    Fed Proc; 1985 Jan; 44(1 Pt 1):66-71. PubMed ID: 2857139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.